|
| Status |
Public on Mar 07, 2021 |
| Title |
RNA-seq of glioma patient tissues treated by DMSO or LY2109761 |
| Organism |
Homo sapiens |
| Experiment type |
Expression profiling by high throughput sequencing
|
| Summary |
Glioma tissues from patients were cultured in complete DMEM and treated with either DMSO or LY2109761, an inhibitor of TGFBR2. Tissue blocks of TBD0207 and TBD0220 were subjected to RNA-seq.
|
| |
|
| Overall design |
Examination of differential expressive genes in glioma tissues treated by DMSO or LY2109761 from patients.
|
| |
|
| Contributor(s) |
Wang Q, Cai J, Zhang J, Kang C |
| Citation(s) |
30279734 |
| Submission date |
Mar 12, 2018 |
| Last update date |
Jun 07, 2021 |
| Contact name |
Jinquan Cai |
| E-mail(s) |
caijinquan666777@126.com
|
| Organization name |
Harbin Medical University
|
| Street address |
Xuefu Road
|
| City |
Harbin |
| ZIP/Postal code |
150086 |
| Country |
China |
| |
|
| Platforms (1) |
|
| Samples (4)
|
|
| This SubSeries is part of SuperSeries: |
| GSE111676 |
Mesenchymal glioblastoma constitutes a major ceRNA signature in the TGF-Beta pathway |
|
| Relations |
| BioProject |
PRJNA437873 |
| SRA |
SRP134910 |
Less...
More...